Skip to main content

Table 1 Five-year overall survival rates for randomized clinical trials of surgery and additional therapy, stratified by trial location (Eastern vs. Western countries)

From: Treatment of localized gastric and gastroesophageal adenocarcinoma: the role of accurate staging and preoperative therapy

Trial Surgery Only Surgery + Chemotherapy Surgery + Chemoradiotherapy
Eastern
 ARTIST [39]   73% 75%
 ACTS-GC [40] 61% 72%  
Western
 CRITICS [41]   41% 41%
 CROSS [16] 34%   47%
 MAGIC [42] 23% 36%  
 FNCLCC/FFCD [43] 24% 38%